THERANOVA (NMN-02/MEDOPP838): Adaptive Diagnostic and Therapeutic Radioligand Platform for Solid Tumors With Active Brain Metastases
Sponsor: Medica Scientia Innovation Research S.L.
Phase:
Disease: Brain metastases from solid tumors, Advanced solid tumors
EU trial number: 2025-523824-39-01
Population: Patients with active brain metastases originating from solid tumors, enrolled into distinct diagnostic or therapeutic agent-specific subcohorts according to target expression and module criteria.
Register Investigator Interest
Interested in offering this trial to suitable patients?